LONDON (Reuters) – U.S. healthcare group Johnson & Johnson is considering a fresh takeover approach for British artificial knee and hip maker Smith & Nephew, the Sunday Times reported without citing sources.
The newspaper said J&J was weighing up whether to make a formal offer for Smith & Nephew worth at least 800 pence a share and valuing the business at more than 7 billion pounds ($11.1 billion), having had a tentative approach pitched at 750p a share rejected last year.
Smith & Nephew, which also has woundcare and endoscopy units, said on Friday it was not currently in talks over a merger or takeover. A spokesman for the company said on Sunday its position had not changed since then.
The company issued a statement on Friday having been at the center of frenzied takeover speculation over the last week.
Sky News had reported that Smith & Nephew received a 7 billion pound ($11.1 billion) or 750p per share approach from J&J last month and the Daily Telegraph reported it had been approached by privately owned U.S. rival Biomet over a possible merger.
J&J said last week it did not comment on rumors or speculation as a matter of policy.
Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.” Email: jackfriday2011(at)hotmail.co.uk
Sunday, January 16, 2011
J&J mulls fresh approach for Smith & Nephew: report - Yahoo! News
via news.yahoo.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment